V. Shetty

847 total citations
9 papers, 643 citations indexed

About

V. Shetty is a scholar working on Hematology, Molecular Biology and Emergency Medicine. According to data from OpenAlex, V. Shetty has authored 9 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 3 papers in Molecular Biology and 3 papers in Emergency Medicine. Recurrent topics in V. Shetty's work include Acute Myeloid Leukemia Research (7 papers), Bone and Joint Diseases (3 papers) and Hematological disorders and diagnostics (3 papers). V. Shetty is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Bone and Joint Diseases (3 papers) and Hematological disorders and diagnostics (3 papers). V. Shetty collaborates with scholars based in United States, United Kingdom and Netherlands. V. Shetty's co-authors include Azra Raza, Suneel Mundle, S. Rifkin, Raphael Borok, S. Alvi, Sefer Gezer, Amna Iftikhar, Agapi Parcharidou, Valéria Buccheri and Daniel Catovsky and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Leukemia.

In The Last Decade

V. Shetty

9 papers receiving 621 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Shetty United States 7 505 250 135 130 105 9 643
Vilasini Shetty United States 15 654 1.3× 328 1.3× 189 1.4× 162 1.2× 38 0.4× 21 811
Sairah Alvi United States 11 461 0.9× 208 0.8× 128 0.9× 110 0.8× 26 0.2× 13 560
Angeline Van Orshoven Belgium 15 488 1.0× 183 0.7× 291 2.2× 111 0.9× 152 1.4× 29 735
Arjan van de Loosdrecht Netherlands 9 547 1.1× 123 0.5× 252 1.9× 105 0.8× 60 0.6× 22 643
Laurie Lisak United States 12 533 1.1× 281 1.1× 182 1.3× 62 0.5× 45 0.4× 15 625
Janet Hayden United Kingdom 6 531 1.1× 102 0.4× 169 1.3× 274 2.1× 51 0.5× 11 648
Hans-Jochen Kölb Germany 8 548 1.1× 99 0.4× 294 2.2× 143 1.1× 74 0.7× 11 666
Margaret M. Showel United States 10 340 0.7× 168 0.7× 67 0.5× 112 0.9× 58 0.6× 29 476
Eva Hellström-Lindberg Sweden 12 761 1.5× 221 0.9× 320 2.4× 229 1.8× 68 0.6× 22 987
I Radford-Weiss France 13 518 1.0× 388 1.6× 120 0.9× 44 0.3× 185 1.8× 19 677

Countries citing papers authored by V. Shetty

Since Specialization
Citations

This map shows the geographic impact of V. Shetty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Shetty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Shetty more than expected).

Fields of papers citing papers by V. Shetty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Shetty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Shetty. The network helps show where V. Shetty may publish in the future.

Co-authorship network of co-authors of V. Shetty

This figure shows the co-authorship network connecting the top 25 collaborators of V. Shetty. A scholar is included among the top collaborators of V. Shetty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Shetty. V. Shetty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Ghia, Paolo, Alan P Skarbnik, Michele Miranda, et al.. (2023). A MATCHING‐ADJUSTED INDIRECT COMPARISON OF THE EFFICACY AND SAFETY OF ACALABRUTINIB VERSUS ZANUBRUTINIB IN RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA. Hematological Oncology. 41(S2). 742–743. 1 indexed citations
2.
Shetty, V., et al.. (2020). Association between metabolic syndrome and Helicobacter pylori infection: A myth or a fact? A cross-sectional study. SHILAP Revista de lepidopterología. 4(1). 41–41. 2 indexed citations
3.
Shetty, V., Suneel Mundle, Laurie Lisak, et al.. (2000). The Clinical and Biologic Significance of Abnormal Lipid Profiles in Patients with Myelodysplastic Syndromes. Journal of Hematotherapy & Stem Cell Research. 9(2). 247–255. 34 indexed citations
4.
Shetty, V., et al.. (2000). Measurement of mRNA expression for a variety of cytokines and its receptors in bone marrows of patients with myelodysplastic syndromes.. PubMed. 19(6B). 5323–8. 30 indexed citations
5.
Mundle, Suneel, Parameswaran Venugopal, V. Shetty, et al.. (1999). The relative extent and propensity of CD34+ vs. CD34- cells to undergo apoptosis in myelodysplastic marrows.. PubMed. 69(3). 152–9. 24 indexed citations
6.
Mundle, Suneel, Gerald M. Feldman, Parneet Cheema, et al.. (1999). Spontaneous down-regulation of Fas-associated phosphatase-1 may contribute to excessive apoptosis in myelodysplastic marrows.. PubMed. 70(2). 83–90. 32 indexed citations
7.
Span, Lambert F. R., et al.. (1998). Apparent expansion of CD34+ cells during the evolution of myelodysplastic syndromes to acute myeloid leukemia. Leukemia. 12(11). 1685–1695. 12 indexed citations
8.
Raza, Azra, Sefer Gezer, Suneel Mundle, et al.. (1995). Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes [see comments]. Blood. 86(1). 268–276. 356 indexed citations
9.
Catovsky, Daniel, Estella Matutes, Valéria Buccheri, et al.. (1991). A classification of acute leukaemia for the 1990s. Annals of Hematology. 62(1). 16–21. 152 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026